176 related articles for article (PubMed ID: 37516111)
21. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
22. Antibody Epitopes of Pneumovirus Fusion Proteins.
Huang J; Diaz D; Mousa JJ
Front Immunol; 2019; 10():2778. PubMed ID: 31849961
[TBL] [Abstract][Full Text] [Related]
23. Antibody recognition of the Pneumovirus fusion protein trimer interface.
Huang J; Diaz D; Mousa JJ
PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
[TBL] [Abstract][Full Text] [Related]
24. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
25. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
26. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
27. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
28. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
Phung E; Chang LA; Mukhamedova M; Yang L; Nair D; Rush SA; Morabito KM; McLellan JS; Buchholz UJ; Mascola JR; Crank MC; Chen G; Graham BS; Ruckwardt TJ
Sci Transl Med; 2022 Jun; 14(650):eabo5032. PubMed ID: 35731888
[TBL] [Abstract][Full Text] [Related]
29. Serological cross-reactivity of members of the Metapneumovirus genus.
Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
[TBL] [Abstract][Full Text] [Related]
30. A tale of two fusion proteins: understanding the metastability of human respiratory syncytial virus and metapneumovirus and implications for rational design of uncleaved prefusion-closed trimers.
Lee YZ; Han J; Zhang YN; Ward G; Gomes KB; Auclair S; Stanfield RL; He L; Wilson IA; Zhu J
bioRxiv; 2024 Mar; ():. PubMed ID: 38496645
[TBL] [Abstract][Full Text] [Related]
31. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
Front Immunol; 2019; 10():706. PubMed ID: 30984206
[No Abstract] [Full Text] [Related]
32. A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F.
Yi C; Su C; Sun X; Lu X; Si C; Liu C; Yang Z; Yuan H; Huang Y; Wen J; He Y; Zhang Y; Ma L; Cong Y; Zhao G; Ling Z; Wang B; Sun B
Sci China Life Sci; 2023 Apr; 66(4):729-742. PubMed ID: 36853487
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection.
Yan XL; Li YN; Tang YJ; Xie ZP; Gao HC; Yang XM; Li YM; Liu LJ; Duan ZJ
J Med Virol; 2017 Apr; 89(4):589-597. PubMed ID: 27632796
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
Bates JT; Pickens JA; Schuster JE; Johnson M; Tollefson SJ; Williams JV; Davis NL; Johnston RE; Schultz-Darken N; Slaughter JC; Smith-House F; Crowe JE
Vaccine; 2016 Feb; 34(7):950-6. PubMed ID: 26772634
[TBL] [Abstract][Full Text] [Related]
35. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
Harshbarger W; Abeyrathne PD; Tian S; Huang Y; Chandramouli S; Bottomley MJ; Malito E
MAbs; 2021; 13(1):1955812. PubMed ID: 34420474
[TBL] [Abstract][Full Text] [Related]
36. Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.
Leemans A; De Schryver M; Van der Gucht W; Heykers A; Pintelon I; Hotard AL; Moore ML; Melero JA; McLellan JS; Graham BS; Broadbent L; Power UF; Caljon G; Cos P; Maes L; Delputte P
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468888
[TBL] [Abstract][Full Text] [Related]
37. Chimeric
Olmedillas E; Cano O; Martínez I; Luque D; Terrón MC; McLellan JS; Melero JA; Más V
EMBO Mol Med; 2018 Feb; 10(2):175-187. PubMed ID: 29217660
[TBL] [Abstract][Full Text] [Related]
38. Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala.
McCracken JP; Arvelo W; Ortíz J; Reyes L; Gray J; Estevez A; Castañeda O; Langley G; Lindblade KA
Influenza Other Respir Viruses; 2014 Jul; 8(4):414-21. PubMed ID: 24761765
[TBL] [Abstract][Full Text] [Related]
39. A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.
Ballegeer M; van Scherpenzeel RC; Delgado T; Iglesias-Caballero M; García Barreno B; Pandey S; Rush SA; Kolkman JA; Mas V; McLellan JS; Saelens X
mBio; 2024 Jan; 15(1):e0212223. PubMed ID: 38117059
[TBL] [Abstract][Full Text] [Related]
40. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
